Skopos Labs, Inc. Haleon PLC Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Skopos Labs, Inc. holds 29,496 shares of HLN stock, worth $326,520. This represents 0.07% of its overall portfolio holdings.
Number of Shares
29,496
Previous 6,080
385.13%
Holding current value
$326,520
Previous $58,000
422.41%
% of portfolio
0.07%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding HLN
# of Institutions
669Shares Held
467MCall Options Held
87.3KPut Options Held
27.2K-
Dodge & Cox San Francisco, CA169MShares$1.87 Billion1.06% of portfolio
-
Clearbridge Investments, LLC New York, NY32.6MShares$361 Million0.3% of portfolio
-
Harding Loevner LP Bridgewater, NJ23.1MShares$255 Million1.89% of portfolio
-
Wellington Management Group LLP Boston, MA18.7MShares$207 Million0.04% of portfolio
-
Ubs Group Ag14.4MShares$159 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $51.1B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...